MicroPort Scientific Corporation has announced a transaction involving its indirect wholly-owned subsidiary, Shanghai Latent. On May 14, 2025, Shanghai Latent entered into a Block Trade Agreement with Placing Agents to dispose of certain assets. This strategic move is part of MicroPort's continuous efforts to innovate and expand its global reach in high-end medical devices, which include cardiovascular, orthopedics, and other specialized medical equipment. The transaction highlights MicroPort's commitment to enhancing its presence in the medical device industry through strategic asset management.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。